Updated Antiretroviral Treatment Guidelines Include Cost Considerations

alt

The U.S. Department of Health and Human Services (DHHS) this week released an update to its Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Among the major changes are the addition of a new section on cost considerations and a recommendation for less frequent CD4 T-cell monitoring for people without advanced disease.

Changes to the guidelines are highlighted in an introductory section, What's New in the Guidelines? Among the key changes in the latest edition:

The guidelines panel welcomes feedback on the revised recommendations. Comments can be e-mailed to JLIB_HTML_CLOAKING with the subject line "Comments on the Adult and Adolescent ARV Guidelines" by May 16, 2014.

5/2/14

Reference

Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. May 1, 2014.

Other Sources

Aids.gov. Updated HHS Adult and Adolescent Antiretroviral Treatment Guidelines Released. blog.AIDS.gov. May 1, 2014.

R Klein, K Struble, and S Morin, FDA. Revised HHS Adult and Adolescent Antiretroviral Treatment Guidelines available. HIV/AIDS Update. May 1, 2014.